In the Healthcare sector, Arlington invests in businesses that provide services, technology or products to the healthcare industry with the goal of reducing overall healthcare system costs and improving quality outcomes. We have historically invested in healthcare companies with limited reimbursement risk in support of founders and management teams that are leaders in their market areas. Within the healthcare sector, Arlington has a strong track record of executing a variety of transactions types including corporate carve-outs, founder recapitalizations and buyouts in partnership with management. In addition, we have made significant investments into large-scale organic and acquisition expansion efforts to increase scale and breadth of offering while improving our portfolio companies' competitive positioning. Sub sectors where we are currently focused include pharma services, medical devices and technology, clinical services, information technology, specialty distribution, animal health and government healthcare.